Multi-layer structure having a predetermined layer pattern including an agent
    1.
    发明申请
    Multi-layer structure having a predetermined layer pattern including an agent 审中-公开
    具有包括试剂的预定层图案的多层结构

    公开(公告)号:US20060269475A1

    公开(公告)日:2006-11-30

    申请号:US11402651

    申请日:2006-04-11

    IPC分类号: A61K51/00 A61K9/14

    摘要: Improved controlled therapy is provided with a polymer multi-layer structure having a predetermined micro-fabricated spatial pattern (e.g., reservoirs and channels). More specifically, all geometrical details of the spatial pattern are substantially predetermined. The increased control of pattern geometry provided by the invention allows for improved control of therapy. In preferred embodiments, the polymer multi-layer structure of the invention is biodegradable, but has an in vivo lifetime that is greater than the duration of the therapy being provided. Thus, the geometrical pattern of the polymer structure that controls delivery of the therapy persists without significant change during therapy, and the structure degrades after completion of therapy. In this manner, possible interference of degradation by-products with therapy is minimized, and delivery of therapy does not depend on details of how degradation proceeds.

    摘要翻译: 提供了具有预定的微制造空间图案(例如储存器和通道)的聚合物多层结构的改进的对照治疗。 更具体地,空间图案的所有几何细节基本上是预先确定的。 由本发明提供的图案几何形状的增加的控制允许改善治疗的控制。 在优选的实施方案中,本发明的聚合物多层结构是可生物降解的,但是具有比所提供的治疗持续时间更长的体内寿命。 因此,控制治疗递送的聚合物结构的几何图案在治疗期间持续而没有显着变化,并且结构在治疗完成后降解。 以这种方式,降解副产物与治疗的可能干扰被最小化,并且治疗的递送不依赖于如何降解进行的细节。

    Thromboresistant surface treatment for biomaterials
    4.
    发明授权
    Thromboresistant surface treatment for biomaterials 失效
    生物材料的抗血栓表面处理

    公开(公告)号:US5578073A

    公开(公告)日:1996-11-26

    申请号:US37335

    申请日:1994-09-16

    摘要: A biomaterial with a thromboresistant surface and a method for forming same are provided. The thromboresistant surface is comprised of a distinct coating layer of a chitosan-based membrane and a biologically active material. The biologically active material is capable of converting the chitosan membrane coating from a highly thrombogenic to an essentially non-thrombogenic one. The biologically active material can be a polymeric substance, such as polyvinyl alcohol, forming a polymeric blend with the chitosan, or, can be a biological substance, such as serum albumin, embedded in or attached to the chitosan membrane which has been activated with a treatment of glutardialdehyde. The thromboresistant biomaterial is suitable for use in vascular grafts having an inside diameter of less than 6 millimeters.

    摘要翻译: 提供具有抗血栓表面的生物材料及其形成方法。 抗血栓表面由基于壳聚糖的膜和生物活性物质的不同的涂层组成。 生物活性物质能够将壳聚糖膜涂层从高度血栓形成转变为基本上非致血性的。 生物活性材料可以是聚合物质,例如聚乙烯醇,与壳聚糖形成聚合物共混物,或者可以是嵌入或连接到壳聚糖膜上的生物物质,例如血清白蛋白,其已经用 治疗戊二醛。 抗血栓生物材料适用于内径小于6毫米的血管移植物。